These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37211171)

  • 1. TANGO1 interacts with NRTN to promote hepatocellular carcinoma progression by regulating the PI3K/AKT/mTOR signaling pathway.
    Man J; Zhou W; Zuo S; Zhao X; Wang Q; Ma H; Li HY
    Biochem Pharmacol; 2023 Jul; 213():115615. PubMed ID: 37211171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
    Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
    Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma.
    Bamodu OA; Chang HL; Ong JR; Lee WH; Yeh CT; Tsai JT
    Cells; 2020 Mar; 9(3):. PubMed ID: 32197467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinoma.
    Rahmani F; Ziaeemehr A; Shahidsales S; Gharib M; Khazaei M; Ferns GA; Ryzhikov M; Avan A; Hassanian SM
    J Cell Physiol; 2020 May; 235(5):4146-4152. PubMed ID: 31663122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells.
    Grabinski N; Ewald F; Hofmann BT; Staufer K; Schumacher U; Nashan B; Jücker M
    Mol Cancer; 2012 Nov; 11():85. PubMed ID: 23167739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VCP interaction with HMGB1 promotes hepatocellular carcinoma progression by activating the PI3K/AKT/mTOR pathway.
    Pu Z; Duda DG; Zhu Y; Pei S; Wang X; Huang Y; Yi P; Huang Z; Peng F; Hu X; Fan X
    J Transl Med; 2022 May; 20(1):212. PubMed ID: 35562734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AURKB targets DHX9 to promote hepatocellular carcinoma progression via PI3K/AKT/mTOR pathway.
    Zhu G; Luo L; He Y; Xiao Y; Cai Z; Tong W; Deng W; Xie J; Zhong Y; Hu Z; Shan R
    Mol Carcinog; 2024 Sep; 63(9):1814-1826. PubMed ID: 38874176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA HAGLROS promotes cell proliferation, inhibits apoptosis and enhances autophagy via regulating miR-5095/ATG12 axis in hepatocellular carcinoma cells.
    Wei H; Hu J; Pu J; Tang Q; Li W; Ma R; Xu Z; Tan C; Yao T; Wu X; Long X; Wang J
    Int Immunopharmacol; 2019 Aug; 73():72-80. PubMed ID: 31082725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piezoeletric cold atmospheric plasma induces apoptosis and autophagy in human hepatocellular carcinoma cells through blocking glycolysis and AKT/mTOR/HIF-1α pathway.
    Wang Y; Mang X; Li D; Chen Y; Cai Z; Tan F
    Free Radic Biol Med; 2023 Nov; 208():134-152. PubMed ID: 37543168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma.
    Song XZ; Ren XN; Xu XJ; Ruan XX; Wang YL; Yao TT
    Technol Cancer Res Treat; 2020; 19():1533033820957023. PubMed ID: 32910747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism.
    Tian LY; Smit DJ; Jücker M
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DZW-310, a novel phosphoinositide 3-kinase inhibitor, attenuates the angiogenesis and growth of hepatocellular carcinoma cells via PI3K/AKT/mTOR axis.
    Wu Y; Xu X; Liu M; Qin X; Wu Q; Ding H; Zhao Q
    Biochem Pharmacol; 2022 Jul; 201():115093. PubMed ID: 35580648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [P4HA2 promotes occurrence and progression of liver cancer by regulating the PI3K/Akt/mTOR signaling pathway].
    Shang L; Jiang W; Zhang J; Wu W
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):665-672. PubMed ID: 35673909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-210 promotes hepatocellular carcinoma progression by modulating macrophage autophagy through PI3K/AKT/mTOR signaling.
    Bi S; Zhang Y; Zhou J; Yao Y; Wang J; Fang M; Li B; Wu C; Ren C
    Biochem Biophys Res Commun; 2023 Jun; 662():47-57. PubMed ID: 37099810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrogen sulfide promotes autophagy of hepatocellular carcinoma cells through the PI3K/Akt/mTOR signaling pathway.
    Wang SS; Chen YH; Chen N; Wang LJ; Chen DX; Weng HL; Dooley S; Ding HG
    Cell Death Dis; 2017 Mar; 8(3):e2688. PubMed ID: 28333142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway.
    Zhang Z; Zhu J; Huang Y; Li W; Cheng H
    Diagn Pathol; 2018 Nov; 13(1):85. PubMed ID: 30390677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-92a-3p Promotes the Malignant Progression of Hepatocellular Carcinoma by Mediating the PI3K/AKT/mTOR Signaling Pathway.
    Wang L; Cui M; Qu F; Cheng D; Yu J; Tang Z; Cheng L; Wei Y; Wu X; Liu X
    Curr Pharm Des; 2021; 27(29):3244-3250. PubMed ID: 34126886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIFC3 regulates progression of hepatocellular carcinoma via EMT and the AKT/mTOR pathway.
    Lu S; Liu Y; Tian S; He Y; Dong W
    Exp Cell Res; 2023 May; 426(1):113564. PubMed ID: 36948354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway.
    Zhang M; Liu S; Chua MS; Li H; Luo D; Wang S; Zhang S; Han B; Sun C
    Cell Death Dis; 2019 Aug; 10(8):612. PubMed ID: 31406106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-37 induces autophagy in hepatocellular carcinoma cells by inhibiting the PI3K/AKT/mTOR pathway.
    Li TT; Zhu D; Mou T; Guo Z; Pu JL; Chen QS; Wei XF; Wu ZJ
    Mol Immunol; 2017 Jul; 87():132-140. PubMed ID: 28433890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.